These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16613383)

  • 1. [Follow-up group for schizophrenic patients using Clozapine and their relatives: the participants' perception].
    Durão AM; de Mello e Souza MC; Miasso AI
    Rev Bras Enferm; 2005; 58(5):524-8. PubMed ID: 16613383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Schizophrenia patients' daily life after the use of clozapine and group accompaniment: Family's view].
    Durão AM; de Mello e Souza MC
    Rev Lat Am Enfermagem; 2006; 14(4):586-92. PubMed ID: 16967166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Daily life of schizofrenia patients after the use of clozapine and group follow up].
    Durão AM; Mello e Souza MC; Miasso AI
    Rev Esc Enferm USP; 2007 Jun; 41(2):251-7. PubMed ID: 17722391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' and relatives' assessment of clozapine treatment.
    Angermeyer MC; Löffler W; Müller P; Schulze B; Priebe S
    Psychol Med; 2001 Apr; 31(3):509-17. PubMed ID: 11305859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Jurgis G; Perlick D; Xu W; Thomas J; Henderson W; Charney D
    J Clin Psychiatry; 2000 Sep; 61(9):671-6. PubMed ID: 11030488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of clozapine and risperidone on spatial working memory in schizophrenia.
    McGurk SR; Carter C; Goldman R; Green MF; Marder SR; Xie H; Schooler NR; Kane JM
    Am J Psychiatry; 2005 May; 162(5):1013-6. PubMed ID: 15863811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine and recidivism.
    Gordon BJ; Milke DJ
    Psychiatr Serv; 1995 Oct; 46(10):1079. PubMed ID: 8829795
    [No Abstract]   [Full Text] [Related]  

  • 9. [Attitude of family to clozapine].
    Angermeyer MC; Boitz K; Löffler W; Müller P; Priebe S
    Psychiatr Prax; 1999 Jul; 26(4):181-7. PubMed ID: 10457970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective experiences of clozapine treatment by patients with chronic schizophrenia.
    Waserman J; Criollo M
    Psychiatr Serv; 2000 May; 51(5):666-8. PubMed ID: 10783189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clozapine experience from a family perspective.
    Dickson RA; Williams R; Dalby JT
    Can J Psychiatry; 1995 Dec; 40(10):627-9. PubMed ID: 8681261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
    Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
    Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine: dangerous orphan or neglected friend?
    Farooq S; Taylor M
    Br J Psychiatry; 2011 Apr; 198(4):247-9. PubMed ID: 21972272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital.
    Stone-Brown K; Naji M; Francioni A; Myers K; Samarendra H; Mushtaq-Chaudhry H; Heslop S; Sengupta S; Ross CC; Larkin F; Das M
    CNS Spectr; 2016 Feb; 21(1):60-9. PubMed ID: 26726766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
    Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
    Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J; Ault K; Powchik P
    Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
    [No Abstract]   [Full Text] [Related]  

  • 19. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.
    Buchanan RW; Breier A; Kirkpatrick B; Ball P; Carpenter WT
    Am J Psychiatry; 1998 Jun; 155(6):751-60. PubMed ID: 9619146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [4 years using clozapine in community psychiatry].
    Fremont P; Bazin N; Pillot B; Lochu A; Colen Demelo P; Pastol I; Zanata G
    Encephale; 1996 Dec; 22 Spec No 6():24-7. PubMed ID: 9102315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.